Device Trial Radar · NCT02003898
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data
Last checked: Nov 20, 2026Latest source record: Mar 5, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
372
Actual
Start
Nov 26, 2013
Primary completion
Feb 20, 2018
Study completion Feb 20, 2018
Sponsor
- Lead sponsor
- Medtronic MiniMed, Inc.Public (MDT)
- Sponsor type
- Industry
- First posted
- Dec 6, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the Threshold Suspend (TS) feature of the Medtronic MiniMed® 530G insulin pump in patients 16 and older with insulin requiring diabetes.
Conditions
- Diabetes
Interventions
Medtronic MiniMed 530G Insulin PumpDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in A1C From Baseline to 1 YearTime frame: 1 year
Locations
43 sites in 1 country. Site status is shown where the registry gives one.
Medical Investigations, Inc.
Little Rock, Arkansas
AMCR Institute
Escondido, California
Valley Research
Fresno, California
40 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.